Abstract

Identifying Drug-Target Interactions (DTIs) is an important process in drug discovery. Traditional experimental methods are expensive and time-consuming for detecting DTIs. Therefore, computational approaches provide many effective strategies to deal with this issue. In recent years, most of computational methods only use the information of drug-drug similarity or target-target similarity, which cannot perfectly capture all characteristics to identify DTIs. In this paper, we propose a novel computational model of DTIs prediction, based on machine learning methods. To improve the performance of prediction, we further use molecular substructure fingerprints, Multivariate Mutual Information (MMI) of proteins and network topology to represent drugs, targets and relationship between them. Moreover, we employ Support Vector Machine (SVM) and Feature Selection (FS) to construct model for predicting DTIs. Experiments of evaluation show that proposed approach achieves better results than other outstanding methods for feature-based DTIs prediction. The proposed approach achieves AUPRs of 0.899, 0.929, 0.821 and 0.655 on Enzyme, Ion Channel (IC), GPCR and Nuclear Receptor datasets, respectively. Compared with existing best methods, AUPRs are increased by 0.016 on Ion Channel datasets. In addition, our method obtains the second best performance on GPCR and Enzyme datasets. The source code and all datasets are available at https://figshare.com/s/53bf5a6065f3911d46f6.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.